Persistence of antibody and response to booster dose of Haemophilus influenzae type b polysaccharide diphtheria toxoid conjugate vaccine in infants immunized at 9 to 15 months of age.
Persistence of antibody and response to booster dose of Haemophilus influenzae type b polysaccharide diphtheria toxoid conjugate vaccine in infants immunized at 9 to 15 months of age.
复制标题
在 9 至 15 个月大的婴儿中,抗体的持久性和对 B 型流感嗜血杆菌多糖白喉类毒素结合疫苗加强剂量的反应。
DOI:
10.1016/s0022-3476(86)80921-0
复制
发表时间:
1986
期刊:
影响因子:
--
通讯作者:
Gordon,L
中科院分区:
文献类型:
--
作者:
Lepow,M;Randolph,M;Cimma,R;Larsen,D;Rogan,M;Schumacher,J;Lent,B;Gaintner,S;Samuelson,J;Gordon,L
At approximately 2 years of age, 27 infants prevlously immunized at 9 to 15 months of age with two doses of polyribosylribifol phosphate-diphtheria toxoid conjugate vaccine (PRP-D) and 23 infants immunized with polyribosyiribitol phosphate (PRP) vaccine were given a single injection of PRP-D. Pre- and post-immunization sera were obtained. No serious local or systemic reactions were observed. The PRP-D reciplents had a geometric mean anti-PRP antibody level of 4.8 μg/ml 1 month after the second primary injection, retained 1.2 μg/ml 1 year later, and had a level of 71 μg/ml after the booster immunization. In contrast, PRP recipients had a geometric mean level of 0.083 μg/ml 1 month after the second primary injection, retained 0.042 μg/ml 1 year later, and after a single dose of PRP-D at approximately 2 years of age had a geometric mean level of 8.6 μg/ml. The significantly higher antibody response in the prior PRP-D recipients suggests the recall of immunologic memory induced by the PRP-D vaccine.